Pages that link to "Q69891308"

The following pages link to High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial (Q69891308):

Displaying 26 items.

• Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts (Q33554366) (← links)
• Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems (Q33611516) (← links)
• Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane (Q33666026) (← links)
• Pharmacokinetically guided administration of chemotherapeutic agents (Q34099816) (← links)
• Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat (Q34211840) (← links)
• The taxoids. Comparative clinical pharmacology and therapeutic potential (Q34456149) (← links)
• Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs (Q35788067) (← links)
• The chemistry of taxol (Q36548501) (← links)
• Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data (Q36745547) (← links)
• Emerging drug treatments for solid tumours (Q36811466) (← links)
• Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report (Q37107594) (← links)
• Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer (Q40397088) (← links)
• Clinical pharmacokinetics of paclitaxel (Q40579192) (← links)
• Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice (Q41558088) (← links)
• Treatment of advanced ovarian carcinoma coexistent with peritoneal tuberculosis (Q41922093) (← links)
• Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis (Q42239440) (← links)
• Pharmacokinetics of paclitaxel in a hemodialysis patient with advanced gastric cancer: A case report. (Q42726296) (← links)
• Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs (Q44677954) (← links)
• Taxol administered as a 120 hour infusion (Q44740889) (← links)
• Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases (Q46150294) (← links)
• A phase II study of taxol in patients with malignant melanoma (Q68298891) (← links)
• Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer (Q71604075) (← links)
• Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces (Q71939519) (← links)
• Taxol and taxotere in bladder cancer: in vitro activity and urine stability (Q72672232) (← links)
• Determinants of paclitaxel uptake, accumulation and retention in solid tumors (Q73973272) (← links)
• The mass spectrometry of taxol (Q86745788) (← links)